RecruitingNot Applicable

Washed Microbiota Transplantation for Clostridioides Difficile Infection

China100 participantsStarted 2023-07-22

Plain-language summary

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation （WMT） for patients with Clostridioides Difficile Infection （CDI）.

Who can participate

Age range3 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. At the time of informed consent, male or non-pregnant or non-lactating female.
✓. The diagnostic criteria for C. difficile infection are met during screening:
✓. Medical records confirming CDI prior to screening (laboratory tests are positive for Clostridium difficile or its toxin): Clostridium difficile toxin test is positive (determined by EIisa test), or colonoscopy indicates pseudomembranous enteritis; Or Glutamate dehydrogenase positive, toxin negative, there are obvious causes and diarrhea.
✓. CDI-related diarrhea episodes, i.e., defecation ≥3 times/day for at least two consecutive days with unformed stools (Bristol score 6-7).
✓. The subject or his/her legal representative gives informed consent, fully understands the purpose of the study, is able to communicate effectively with the investigator, and comprehends and complies with the requirements set forth in the study.

Exclusion criteria

✕. Subjects with immune deficiencies (such as HIV infection, or neutrophils \<0.5×109/L in absolute value, or lymphocytes \<0.5×109/L, etc.), or on immunosuppressants, or on medium to high doses of steroid hormones (≥20g/d of prednisone or equal doses of steroid hormones).
✕. There is rectal outlet obstruction (such as rectal mucosal prolapse) or significant intestinal stenosis assessed by the investigator and colonic transendoscopic enteral tubing cannot be performed.
✕. Confirmed or clinically suspected infection with pathogenic microorganisms other than Clostridium difficile prior to screening.
✕. Have had major abdominal surgery (other than laparoscopic gallbladder or appendectomy), previous partial or total colectomy, previous partial small intestinal resection, or previous gastroduodenal surgery within 6 months prior to screening.
✕. At the time of screening, the subject or his/her legal representative refuses to take effective contraception within 3 months after the last treatment.
✕. According to the judgment of the investigator, the subjects are not suitable to participate in this clinical study, or participation in this clinical study cannot guarantee the rights and interests of the subjects.

What they're measuring

The incidence of treatment-related adverse events (AE) assessed by CTCAE, Version 5.0

Timeframe: Four-week post-WMT

Trial details

NCT IDNCT06106698

SponsorThe Second Hospital of Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-07

Contact for this trial

Faming Zhang, PhD

086-025-58509883 fzhang@njmu.edu.cn

View on ClinicalTrials.gov More Clostridioides Difficile Infection trials